Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degeneration: Low-dose clinical outcomes

Cell stem cell(2025)10.1016/j.stem.2025.08.012Source: DataRank Database

Safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degeneration: Low-dose clinical outcomes is a research paper published in Cell stem cell (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: hybridTopics (21)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Brigitte L. Arduini ORCID,Susan L. Borden,Dhruv Sareen ORCID,Clive N. Svendsen ORCID,Paul P. Lee ORCID

Live enrichment

PubMed:40961946 PMC:PMC12533590

National Eye Institute

Grant: U01EY030581

National Eye Institute

Grant: UGEY031810

NEI NIH HHS

Grant: UG3 EY031810

NEI NIH HHS

Grant: UH3 EY031810

National Institutes of Health

hybridLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.stem.2025.08.012

publisherhttps://api.elsevier.com/content/article/PII:S1934590925003042?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1934590925003042?httpAccept=text/plain

Europe_PMChttps://europepmc.org/articles/PMC12533590

Europe_PMChttps://europepmc.org/articles/PMC12533590?pdf=render

MeSH Terms

Stem CellsHumansMacular DegenerationTreatment OutcomeStem Cell TransplantationVisual AcuityAgedAged, 80 and overMiddle AgedFemaleMaleRetinal Pigment EpitheliumGeographic Atrophy

Keywords

RetinaVisionAdult stem cellCell therapyMacular degenerationretinal pigment epitheliumClinical TrialGeographic Atrophy

Safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degeneration: Low-dose clinical outcomes

FAIR Checklist

Authors (16)

Funding (5 grants)

Open Access

Topics

Annotations (Europe PMC)